Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
Hepatocellular carcinoma (HCC) mortality rates are increasing globally, and particularly in
the Western world. Cirrhosis remains the predominant risk factor for HCC. However …
the Western world. Cirrhosis remains the predominant risk factor for HCC. However …
Hepatocellular carcinoma surveillance—Utilization, barriers and the impact of changing aetiology
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …
[HTML][HTML] Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions
YB Liu, MK Chen - World journal of gastroenterology, 2022 - ncbi.nlm.nih.gov
Cirrhosis causes a heavy global burden. In this review, we summarized up-to-date
epidemiological features of cirrhosis and its complications. Recent epidemiological studies …
epidemiological features of cirrhosis and its complications. Recent epidemiological studies …
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, in
part because of inadequate early detection strategies. Current recommendations for …
part because of inadequate early detection strategies. Current recommendations for …
[PDF][PDF] International Liver Cancer Association (ILCA) white paper on biomarker development for hepatocellular carcinoma
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for
Hepatocellular Carcinoma Page 1 1 International Liver Cancer Association (ILCA) White Paper …
Hepatocellular Carcinoma Page 1 1 International Liver Cancer Association (ILCA) White Paper …
Validation of a novel multitarget blood test shows high sensitivity to detect early stage hepatocellular carcinoma
Background & Aims Hepatocellular carcinoma (HCC) is a leading cause of cancer-related
death worldwide. Although biannual ultrasound surveillance with or without α-fetoprotein …
death worldwide. Although biannual ultrasound surveillance with or without α-fetoprotein …
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
Abstract Background and Aims Most patients with HCC are diagnosed at a late stage,
highlighting the need for more accurate surveillance tests. Although biomarkers for HCC …
highlighting the need for more accurate surveillance tests. Although biomarkers for HCC …
Barriers to surveillance for hepatocellular carcinoma in a multicenter cohort
Importance Hepatocellular carcinoma (HCC) surveillance is underused in clinical practice,
which may be owing to patient and clinician barriers. Objective To characterize HCC …
which may be owing to patient and clinician barriers. Objective To characterize HCC …
Conceptual model for the hepatocellular carcinoma screening continuum: current status and research agenda
Hepatocellular carcinoma (HCC) continues to have a dismal prognosis, with 5-year survival
below 20%. This poor prognosis can be in part attributed to failures along the cancer …
below 20%. This poor prognosis can be in part attributed to failures along the cancer …